Alpha Cognition (ACOG) Gains from Investment Securities (2023 - 2025)
Alpha Cognition's (ACOG) quarterly Gains from Investment Securities came in at -$3.7 million in Q3 2025, down 520.51% year-on-year from $873175.9 in Q3 2024, and down 170.99% quarter-over-quarter from $5.2 million in Q2 2025.
Alpha Cognition (ACOG) Gains from Investment Securities (2023 - 2025) Analysis & Trends
Alpha Cognition's Gains from Investment Securities history runs 3 years deep, the most recent figure standing at -$3.7 million for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,831.58 Bn | 66,831.30 Bn | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - |
| 3 | Akari Therapeutics | 976.78 Bn | 976.78 Bn | - |
| 4 | BeOne Medicines | 471.48 Bn | 466.69 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.78 Bn | 114.53 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.54 Bn | 34.53 Bn | 959.66 Mn |
| 10 | Alpha Cognition | 146.84 Mn | 80.73 Mn | 2.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3.67 Mn |
| Sep 30, 2025 | -3.67 Mn |
| Jun 30, 2025 | 5.17 Mn |
| Jun 30, 2025 | 5.17 Mn |
| Sep 30, 2024 | -591,736.00 |
| Sep 30, 2024 | -591,736.00 |
| Jun 30, 2024 | -187,056.00 |
| Jun 30, 2024 | -187,056.00 |
| Sep 30, 2023 | 515,771.00 |
| Sep 30, 2023 | 515,771.00 |
| Jun 30, 2023 | 71,856.00 |
| Jun 30, 2023 | 71,856.00 |